BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10606935)

  • 1. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
    Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
    Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
    Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.
    Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; Hamid QA
    J Allergy Clin Immunol; 1998 Mar; 101(3):330-6. PubMed ID: 9525448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
    Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment.
    Laberge S; Durham SR; Ghaffar O; Rak S; Center DM; Jacobson M; Hamid Q
    J Allergy Clin Immunol; 1997 Oct; 100(4):569-74. PubMed ID: 9338554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
    Greiff L; Petersen H; Mattsson E; Andersson M; Erjefält JS; Linden M; Svensson C; Persson CG
    Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
    Ciprandi G; Tosca MA; Passalacqua G; Canonica GW
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.
    Bradding P; Feather IH; Wilson S; Holgate ST; Howarth PH
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1900-6. PubMed ID: 7767538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid.
    Nouri-Aria KT; Masuyama K; Jacobson MR; Rak S; Lowhagen O; Schotman E; Hamid Q; Durham S
    Int Arch Allergy Immunol; 1998 Dec; 117(4):248-54. PubMed ID: 9876226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor.
    Cameron L; Christodoulopoulos P; Lavigne F; Nakamura Y; Eidelman D; McEuen A; Walls A; Tavernier J; Minshall E; Moqbel R; Hamid Q
    J Immunol; 2000 Feb; 164(3):1538-45. PubMed ID: 10640772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine expression during allergen-induced late nasal responses: IL-4 and IL-5 mRNA is expressed early (at 6 h) predominantly by eosinophils.
    Nouri-Aria KT; O'Brien F; Noble W; Jabcobson MR; Rajakulasingam K; Durham SR
    Clin Exp Allergy; 2000 Dec; 30(12):1709-16. PubMed ID: 11122208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid.
    Durham SR; Gould HJ; Thienes CP; Jacobson MR; Masuyama K; Rak S; Lowhagen O; Schotman E; Cameron L; Hamid QA
    Eur J Immunol; 1997 Nov; 27(11):2899-906. PubMed ID: 9394816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation.
    Baroody FM; Rouadi P; Driscoll PV; Bochner BS; Naclerio RM
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):899-906. PubMed ID: 9517609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.
    Benson M; Strannegård IL; Strannegård O; Wennergren G
    J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide.
    Wang JH; Devalia JL; Rusznak C; Bagnall A; Sapsford RJ; Davies RJ
    Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Ying S; Durham SR; Jacobson MR; Rak S; Masuyama K; Lowhagen O; Kay AB; Hamid QA
    Immunology; 1994 Jun; 82(2):200-6. PubMed ID: 7927489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced T-bet in addition to enhanced STAT6 and GATA3 expressing T cells contribute to human allergen-induced late responses.
    Eifan AO; Furukido K; Dumitru A; Jacobson MR; Schmidt-Weber C; Banfield G; Durham SR; Nouri-Aria KT
    Clin Exp Allergy; 2012 Jun; 42(6):891-900. PubMed ID: 22909160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: effect of topical corticosteroids.
    Christodoulopoulos P; Wright E; Frenkiel S; Luster A; Hamid Q
    J Allergy Clin Immunol; 1999 Jun; 103(6):1036-44. PubMed ID: 10359883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of the transcription factor GATA-3 in upper airway mucosa after in vivo and in vitro allergen challenge.
    Nakamura Y; Christodoulopoulos P; Cameron L; Wright E; Lavigne F; Toda M; Muro S; Ray A; Eidelman DH; Minshall E; Hamid Q
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1146-52. PubMed ID: 10856149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.